Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07890285) titled 'A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in Korea' on Oct. 16.
Study Type: Observational
Primary Sponsor: Janssen Korea, Ltd., Korea
Condition:
Pulmonary Arterial Hypertension
Recruitment Status: Not recruiting
Date of First Enrollment: November 2, 2026
Target Sample Size: 333
To know more, visit https://clinicaltrials.gov/study/NCT07890285
Disclaimer: Curated by HT Syndication....